This is a very rare and aggressive type of cancer that starts in the tissues that normally grow the placenta during pregnancy. It's a form of gestational trophoblastic disease. It can spread quickly to other parts of the body.
Every report comes from a Lived member, sent anonymously.
Have you tried Methotrexate for Choriocarcinoma?
Choriocarcinoma is a rare, fast-growing cancer that develops from trophoblast cells, the cells that normally form part of the placenta during pregnancy. Instead of supporting a pregnancy, these cells grow into a tumor that invades the wall of the uterus and its blood vessels. Because it travels through the bloodstream, it can spread early to the lungs and sometimes to the brain, liver or other organs. Most choriocarcinomas follow a pregnancy and belong to a group of conditions called gestational trophoblastic neoplasia (GTN), the cancerous forms of gestational trophoblastic disease. Despite how aggressive it can be, gestational choriocarcinoma is one of the most treatable cancers: it usually responds very well to chemotherapy, even after it has spread. Choriocarcinoma can also arise, much less often, from germ cells in the testis or ovary. That non-gestational form is treated as a germ cell cancer, along different lines from the pregnancy-related disease described on this page.
Gestational choriocarcinoma starts in placental tissue left behind after a pregnancy. It most often follows a molar pregnancy, in which a fertilized egg develops into abnormal placental tissue instead of a healthy pregnancy, particularly a complete mole. It can also follow a miscarriage, an ectopic (tubal) pregnancy or, more rarely, a normal birth, sometimes months or years later. The main known risk factors are a previous molar pregnancy and pregnancy before age 20 or after 35. Nothing a person did during pregnancy is known to cause it, and most people with these risk factors never develop choriocarcinoma. It is uncommon: in the United States it occurs in roughly 2 to 7 of every 100,000 pregnancies.
The key test is a blood level of hCG (human chorionic gonadotropin), the pregnancy hormone that choriocarcinoma produces in large amounts. A high or rising hCG when someone is not pregnant, or an hCG that stops falling after a molar pregnancy has been removed, points toward a trophoblastic tumor. Choriocarcinoma may be found this way during routine monitoring after a molar pregnancy, or when someone has unexplained bleeding after a pregnancy, or symptoms from spread such as cough, shortness of breath or neurological changes. A pelvic ultrasound looks at the uterus, and a chest X-ray or CT scan checks the lungs. Because choriocarcinoma can spread to the brain and liver, MRI or CT of the brain and abdomen is also usual. Blood tests check the liver, kidneys and blood counts. When tissue is available, for example after a uterine procedure, examining it under the microscope confirms the diagnosis. The results are combined into a stage, which describes how far the cancer has spread, and a risk score, developed by the International Federation of Gynecology and Obstetrics (FIGO), that counts factors such as the hCG level, the time since the pregnancy, the size of the tumor, and how many places and which organs the cancer has reached. A score of 6 or below means low-risk disease; 7 or above means high-risk disease. The score, rather than the stage alone, guides how intensive treatment needs to be.
Chemotherapy is the main treatment, and it is usually curative. Treatment is ideally planned with a specialist center experienced in trophoblastic disease, because these tumors are rare and the details of choosing and switching drugs matter. Low-risk disease is generally treated with a single chemotherapy drug, either methotrexate or actinomycin-D (dactinomycin), given in repeated cycles every week or two. About 3 in 10 people need to switch to a second drug or a combination because hCG stops falling, but survival in low-risk disease approaches 100%. At the upper end of the low-risk range, a score of 5 or 6, choriocarcinoma is more likely to resist a single drug, so current FIGO guidance recommends starting with combination chemotherapy instead. Single-drug treatment remains the usual approach at lower scores. High-risk disease is treated with combination chemotherapy, most often a regimen called EMA-CO (etoposide, methotrexate, actinomycin-D, cyclophosphamide and vincristine). It is more demanding, with more hair loss, nausea, fatigue and low blood counts, but overall survival in high-risk disease now exceeds 90% at experienced centers. When the cancer resists chemotherapy, other drug combinations or immunotherapy with pembrolizumab (Keytruda), a medicine that helps the immune system attack cancer cells, can still bring lasting remission for many people. In every case, treatment continues for a few extra cycles after hCG returns to normal to lower the chance of relapse. Surgery plays a supporting role: removing the uterus (hysterectomy) may be considered for someone who does not want future pregnancies or for bleeding that cannot be controlled, and removing an isolated tumor that resists drugs can be curative. A hysterectomy does not replace monitoring: hCG is still followed afterward, and chemotherapy is usually still needed. Radiation is mainly used for selected brain metastases.
The outlook for gestational choriocarcinoma is very good compared with most cancers that spread. Spread only to the lungs still has a high cure rate. The outlook is less certain when the cancer has reached the liver or brain, when the score is very high, or when the cancer appears long after the pregnancy, and these situations need more intensive treatment. Regular hCG blood tests, often weekly, become the main measure of progress, and cycles are repeated until hCG has returned to normal and stayed there for several weeks. Side effects of single-drug treatment are often manageable alongside daily life, while combination therapy is harder and may limit work and other responsibilities for a time. After treatment, hCG is checked monthly for at least a year so that any relapse can be caught early, when it is still very treatable. Reliable contraception is used throughout this period, because a pregnancy would raise hCG and hide the signal doctors are watching for. Most people who keep their uterus can go on to have healthy pregnancies later, and fertility is typically not affected. The experience of a pregnancy turning into a cancer diagnosis can be emotionally hard, and counseling or support groups can help.
Ask for an evaluation if vaginal bleeding continues longer than expected after a birth, miscarriage or pregnancy loss, or if you are not pregnant but have a positive pregnancy test. If you have had a molar pregnancy, keep every scheduled hCG test even when you feel well. During treatment or follow-up, contact your care team right away for heavy vaginal bleeding, coughing up streaks or small amounts of blood, or new or worsening shortness of breath. If a blood test shows your hCG has risen, ask the team promptly what it means for your treatment. Choriocarcinoma can bleed suddenly where it grows or has spread. Call 911 for very heavy vaginal bleeding with fainting or lightheadedness, coughing up more than a few teaspoons of blood, or sudden severe belly pain. Also call 911 for a seizure, a sudden severe headache, or sudden trouble speaking, seeing, moving one side of the body or staying alert, which can signal bleeding in the brain.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Choriocarcinoma is like, what's helped you, or ask the community a question.